SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-051616
Filing Date
2021-04-19
Accepted
2021-04-19 07:02:41
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tm2113290-1_10ka.htm 10-K/A 36613
  Complete submission text file 0001104659-21-051616.txt   4671344

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT catb-20201231.xml EX-101.INS 1353244
3 XBRL TAXONOMY EXTENSION SCHEMA catb-20201231.xsd EX-101.SCH 44166
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE catb-20201231_cal.xml EX-101.CAL 46815
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE catb-20201231_lab.xml EX-101.LAB 426045
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE catb-20201231_pre.xml EX-101.PRE 307974
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE catb-20201231_def.xml EX-101.DEF 150528
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37467 | Film No.: 21833151
SIC: 2834 Pharmaceutical Preparations